Full Text
PSY13 Effect of Risk-Share Agreements on Budget Impact- A Case Study of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Abstract

Authors

K. Fust A. Parthan A.K. O'Sullivan A. Bedenbaugh

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×